TABLE 1. Anti-hypertensive Drugs to Treat Gestational Hypertension or Pre-eclampsia without Severe Features.1,35.
|
Agent |
Dose |
Recommendation |
Side effects |
|
|
First line |
Labetalol (oral) |
Initial dose: 100-200 mg twice a day Increase every 2-3 days Maximum dose 2,400 mg/day |
Consider adding another low-dose medication if BP is not controlled with 200 mg, 3-4 times/day |
Hypotension, increased liver enzyme levels, fetal bradycardia, neonatal hypoglycemia |
|
Extended release nifedipine (oral) |
Initial dose: 30-60 mg every day Increase every 7-14 days Maximum dose 120 mg/day |
Consider adding another low-dose medication if BP is not controlled with 60 mg/day |
Risk of bronchospasm (avoid in asthma), severe headache, peripheral edema, anxiety, nightmares, dry mouth, hypotension. Contraindicated in aortic stenosis |
|
|
Alpha-methyldopa (oral) |
Initial dose: 250 mg twice or three times a day Increase every two days Maximum dose 3,000 mg/day |
Consider adding another low-dose medication if BP is not controlled with 500 mg, four times/day |
Contraindicated in depression |
|
|
Second or third line |
Hydralazine |
Initial dose: 10 mg four times a day Increase every 2-5 days Maximum dose 200 mg/day |
Care should be taken when using because half of women experience associated side effects |
Tachycardia (should never be used in isolation because of reflex tachycardia), headache, flushing, fetal distress, hypotension |
|
Hydrochlorothiazide |
Initial dose: 12.5 mg every day Increase every 7-14 days Max. dose 200 mg/day |
The use of thiazide diuretics can be associated with significant volume depletion within the first two weeks and intensive monitoring of volume status is recommended |
Volume depletion, FGR, oligohydramnios |
BP, blood pressure; FGR, fetal growth restriction.